Fluzone (influenza vaccine) has potential interactions with other medications. These interactions could affect how well the drug works or cause harmful effects. Fluzone is used in people ages 6 ...

Earnings Call Transcript January 30, 2025 Sanofi misses on earnings expectations. Reported EPS is $0.7 EPS, expectations were ...

Head of Investor Relations Welcome to the Q4 and full year 2024 conference call for investors and analysts. As usual, you can find the slides on sanofi.com. Please turn to Slide 3. Here we have the ...

After two years characterized by layoffs, pipeline reorganizations, FDA delays and clinical holds, Novavax CEO John Jacobs ...

Fluzone High Dose is an inactivated influenza vaccine indicated for those aged 65 years or older against influenza disease caused by the strains of the influenza A and B subtypes contained within ...

The trial looked at the efficacy of mRNA-1083 in one group of adults 65 years and older who received Moderna’s jab or Sanofi’s high-dose flu vaccine Fluzone HD, co-administered with Moderna ...

Fluzone QIV HD is under clinical development by Sanofi and currently in Phase II for Unspecified Influenza Virus Infections. According to GlobalData, Phase II drugs for Unspecified Influenza Virus ...

Q4 guidance included expanded metrics for 2025, such as mid to high single-digit sales growth and low double-digit EPS growth, compared to a more cautious outlook in Q3. Management also introduced a ...

Merck shares trade at a significant discount to peers. The company faces challenges, but there are reasons to be bullish.

Background Because inactivated trivalent influenza vaccines (TIVs) contain 1 influenza B strain, whereas 2 lineages may co-circulate, B lineage mismatch is frequent. We assessed an inactivated ...

Influenza (flu) is a viral infection that affects tens of millions of people across the planet every year. As influenza mutates rapidly, the most common strains change each flu season, and a new ...